| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | NCI-H69/CPR |
|---|
| Description | NCI-H69/CPR is a drug resistant subline of NCI-H69. Drug resistance was developed by addition of a stepwise increase in cisplatin to the growth medium of the parental line. The cell line exhibits a 5-fold resistance to cisplatin and is cross resistant to melphalan. A significant change in cellular glutathione content or sensitivity to cadmium chloride (as indicator of metallothionein content) was not detected, but changes in glutathione-S-transferase activity were seen. Cisplatin accumulation was unchanged compared with the parent line. It is recommended to culture the cells without drugs after resuscitation until the first passage. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | CSC-C9513J |
|---|
| Price | |
|---|
| Order / More Info | NCI-H69/CPR from CREATIVE BIOARRAY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|